Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of renal angioplasty for fibromuscular dysplasia in Asian vs. white patients: a systematic review and meta-analysis.

Journal of hypertension·2026
Same author

The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).

Journal of the American College of Cardiology·2026
Same author

Personalised surveillance for aortic stenosis progression: a work in progress.

Heart (British Cardiac Society)·2026
Same author

Belgian recommendations for tissue diagnosis of amyloidosis.

Acta clinica Belgica·2026
Same author

Tafamidis in women with wild-type transthyretin cardiac amyloidosis: an international cohort study.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A Mendelian Randomization Study.

Circulation. Genomic and precision medicine·2026
Same journal

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.

Circulation. Heart failure·2026
Same journal

Letter by Zhang Regarding Article, "Improving Heart Failure Quality of Care Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program".

Circulation. Heart failure·2026
Same journal

Response by Fonarow et al to Letter Regarding Article, "Improving Heart Failure Quality of are Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program".

Circulation. Heart failure·2026
Same journal

Letter by Ragozzino and Mattera et al Regarding Article, "What Exactly Is Cardiometabolic HFpEF: A Phenotype or an Endotype?"

Circulation. Heart failure·2026
Same journal

Response by McMurray to Letter Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".

Circulation. Heart failure·2026
Same journal

Letter by Nie and Xiong Regarding Article, "Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF".

Circulation. Heart failure·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.

Dorit Knappe1, Anne-Catherine Pouleur, Amil M Shah

  • 1Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA 02115, USA.

Circulation. Heart Failure
|May 24, 2011
PubMed
Summary
This summary is machine-generated.

Cardiac resynchronization therapy (CRT) benefits patients with heart failure. Combining assessments of left ventricular dyssynchrony and contractile function identifies patients most likely to respond to CRT.

More Related Videos

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

Related Experiment Videos

Last Updated: Jun 1, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) improves outcomes in heart failure, but about 30% of patients do not respond fully.
  • Identifying non-responders is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate if combined assessment of left ventricular (LV) dyssynchrony and contractile function using strain-based imaging can predict CRT benefit.
  • To identify patient subgroups most likely to benefit from CRT.

Main Methods:

  • 1077 patients with heart failure (NYHA class I/II, LVEF ≤30%, QRS width ≥130 ms) from the MADIT-CRT trial were analyzed.
  • Echocardiographic assessments included LV dyssynchrony (standard deviation of time-to-peak transverse strain) and global longitudinal strain (GLS).
  • Treatment effect on death or heart failure events was evaluated based on baseline imaging parameters.

Main Results:

  • The greatest benefit from CRT was observed in patients with mild to moderate dyssynchrony (142-230 ms) and better baseline contractile function (GLS ≤-8.7%).
  • Patients with both mild/moderate dyssynchrony and best contractile function showed the largest CRT benefit (aHR 0.20).
  • Dyssynchrony and GLS independently predicted CRT response, even when accounting for QRS width, LVEF, and left bundle-branch block.

Conclusions:

  • Both mechanical dyssynchrony and myocardial contractile function are significant independent predictors of CRT response.
  • Strain-based imaging parameters can refine patient selection for CRT.